Automated description from the Alliance of Genome Resources (Release 7.0.0)
Enables histone acetyltransferase activity. Acts upstream of or within cellular response to leukemia inhibitory factor and chromatin remodeling. Predicted to be part of MOZ/MORF histone acetyltransferase complex. Predicted to be active in nucleus. Is expressed in several structures, including brain; early conceptus; facial prominence; genitourinary system; and limb mesenchyme. Used to study Noonan syndrome. Human ortholog(s) of this gene implicated in bipolar disorder; blepharophimosis-intellectual disability syndrome, SBBYS type; breast cancer; and leiomyoma. Orthologous to human KAT6B (lysine acetyltransferase 6B).